NCT03042442 (CDNPAN) is a clinical trial of Point-of care biomarkers in Pancreatic Cancer, Adult, sponsored by Iuliu Hatieganu University of Medicine and Pharmacy.

Who is sponsoring NCT03042442?

NCT03042442 is sponsored by Iuliu Hatieganu University of Medicine and Pharmacy.

What drugs are being tested in NCT03042442?

Interventions in NCT03042442: Point-of care biomarkers, Clinical, venous blood samples, pancreatic tissue, Follow-up.

What condition does NCT03042442 study?

NCT03042442 studies Pancreatic Cancer, Adult, Cachexia, Pain, Diabetes Mellitus.

Is NCT03042442 still recruiting?

NCT03042442 is currently completed. Last updated 19 March 2019.

Last reviewed 2019-03-19 · How we verify

NCT03042442: CDNPAN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy

Completed Last updated 19 March 2019

What this trial tests

trial testing Point-of care biomarkers in Pancreatic Cancer, Adult in 114 participants. Completed in 30 September 2018.

Timeline

1 January 2017

Primary endpoint
30 June 2018

30 September 2018

Quick facts

Lead sponsor	Iuliu Hatieganu University of Medicine and Pharmacy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	114
Start date	1 January 2017
Primary completion	30 June 2018
Estimated completion	30 September 2018
Sites	1 location across Romania

Drugs / interventions tested

Point-of care biomarkers
Clinical, venous blood samples, pancreatic tissue
Follow-up

Conditions studied

Pancreatic Cancer, Adult — all drugs for Pancreatic Cancer, Adult →
Cachexia — all drugs for Cachexia →
Pain — all drugs for Pain →
Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Iuliu Hatieganu University of Medicine and Pharmacy

Who can join

Adults 18 to 100, any sex, with Pancreatic Cancer, Adult or Cachexia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the interrelationship between cachexia, neural invasion and diabetes in patients with pancreatic cancer. Thus the investigators propose to identify the protein expression levels of Activin and Midkine in plasma of patients with different stages of pancreatic adenocarcinoma compared with healthy patients and to evaluate the possible correlation with diabetes, tumor size and tumor stage.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma.
Petrusel L, Rusu I, Leucuta DC, Seicean R, et al · · 2019 · cited 6× · PMID 31908718 · DOI 10.4251/wjgo.v11.i12.1126
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: Recapitulating Its Importance and Defining Future Directions.
Lovecek M, Dirimtekin E, Garajová I, Gasparini G, et al · · 2025 · cited 2× · PMID 40981722 · DOI 10.1002/ueg2.70118

Verify or expand the search:

Other recruiting trials for Pancreatic Cancer, Adult

Currently open trials in the same condition.

NCT06717295 — The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel · recruiting
NCT06852014 — Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticod · NA · recruiting
NCT06584227 — Adebrelimab and Chidamide for Pancreatic Cancer · Phase 2 · recruiting
NCT06388967 — Pancreatic Cancer Detection Consortium · recruiting
NCT06822413 — Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis · recruiting

Other Iuliu Hatieganu University of Medicine and Pharmacy trials

Trials by the same sponsor.

NCT07397091 — Using Routine Inflammatory and Metabolic Blood Tests (Bedside Included) to Predict Brain Injury in Children After Minor · not yet recruiting
NCT07362173 — Actualities in Procedural Sedation: Remimazolam · Phase 4 · active not recruiting
NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting
NCT06251869 — Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty (Electrocoagulation vs Scalpel) · recruiting
NCT06283836 — Dexmedetomidine vs. Remifentanil Conscious Sedation for Stapedotomy/Stapedectomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03042442 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iuliu Hatieganu University of Medicine and Pharmacy
Last refreshed: 19 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03042442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing